These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 19631779

  • 1. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
    Tanaka H, Hamano T, Fujii N, Tomida K, Matsui I, Mikami S, Nagasawa Y, Ito T, Moriyama T, Horio M, Imai E, Isaka Y, Rakugi H.
    Bone; 2009 Nov; 45(5):949-55. PubMed ID: 19631779
    [Abstract] [Full Text] [Related]

  • 2. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H.
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [Abstract] [Full Text] [Related]

  • 3. Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23.
    Mazzaferro S, Pasquali M, Pugliese F, Citterio F, Gargiulo A, Rotondi S, Tartaglione L, Conte C, Pirrò G, Taggi F.
    J Nephrol; 2012 Apr; 25(6):1108-18. PubMed ID: 22383345
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of FGF-23 measurement in dialysis patients.
    Jongbloed F, Galassi A, Cozzolino M, Zietse R, Chiarelli G, Cusi D, Brancaccio D, Gallieni M.
    Clin Nephrol; 2011 Sep; 76(3):201-9. PubMed ID: 21888857
    [Abstract] [Full Text] [Related]

  • 5. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ, Harjes LM, Dembek K, Young GS, Chew DJ, Toribio RE.
    J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
    [Abstract] [Full Text] [Related]

  • 6. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D, Sankaralingam A, Scully P, Manghat P, Goldsmith D, Hampson G.
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [Abstract] [Full Text] [Related]

  • 7. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 8. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K, Masajtis-Zagajewska A, Nowicki M.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [Abstract] [Full Text] [Related]

  • 9. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
    Nakano C, Hamano T, Fujii N, Obi Y, Matsui I, Tomida K, Mikami S, Inoue K, Shimomura A, Nagasawa Y, Okada N, Tsubakihara Y, Rakugi H, Isaka Y.
    Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
    [Abstract] [Full Text] [Related]

  • 10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jun; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W, Nessel L, Anderson AH, Lo J, Porter A, Nunes JW, Negrea L, Hamm L, Horwitz E, Chen J, Scialla JJ, de Boer IH, Leonard MB, Feldman HI, Wolf M, CRIC Study Investigators.
    Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
    [Abstract] [Full Text] [Related]

  • 12. Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
    Kim CS, Bae EH, Ma SK, Han SH, Lee KB, Lee J, Oh KH, Chae DW, Kim SW, KNOW-CKD Study Group.
    J Korean Med Sci; 2017 Feb; 32(2):240-248. PubMed ID: 28049234
    [Abstract] [Full Text] [Related]

  • 13. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
    Zehnder D, Landray MJ, Wheeler DC, Fraser W, Blackwell L, Nuttall S, Hughes SV, Townend J, Ferro C, Baigent C, Hewison M.
    Nephron Clin Pract; 2007 Feb; 107(3):c109-16. PubMed ID: 17890873
    [Abstract] [Full Text] [Related]

  • 14. Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in Japan.
    Hamano T, Fujii N, Matsui I, Nakano C, Inoue K, Tomida K, Mikami S, Okada N, Tsubakihara Y, Rakugi H, Isaka Y.
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():2-8. PubMed ID: 21595844
    [Abstract] [Full Text] [Related]

  • 15. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephron Clin Pract; 2008 Jun; 110(1):c58-65. PubMed ID: 18724068
    [Abstract] [Full Text] [Related]

  • 16. [Clinical and biochemical characteristics of predialysis patients in terms of 25 hydroxy vitamin D levels].
    Rodríguez Villarreal I, Ortega O, Gallar P, Sánchez M, Callejas R, Gracia C, García la Calle C, Ortiz M, Herrero JC, Mon C, Oliet A, Vigil A.
    Nefrologia; 2011 Jun; 31(2):185-91. PubMed ID: 21461012
    [Abstract] [Full Text] [Related]

  • 17. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
    Sprague SM, Wetmore JB, Gurevich K, Da Roza G, Buerkert J, Reiner M, Goodman W, Cooper K.
    Clin J Am Soc Nephrol; 2015 Jun 05; 10(6):1021-30. PubMed ID: 25873267
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K, Hamano T, Ichimaru N, Fujii N, Matsui I, Nonomura N, Tsubakihara Y, Rakugi H, Takahara S, Isaka Y.
    Bone; 2012 Oct 05; 51(4):729-36. PubMed ID: 22796419
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.